Sentences with phrase «prevent organ rejection»

Those medications include cyclosporin (Atopica ©), given to cats to help control skin allergies, eosinophilic granuloma or to prevent organ rejection.

immune - mediated skin diseases, autoimmune hemolytic anemia, thrombocytopenia, rheumatoid arthritis, inflammatory bowel disease, polyarthritis and more) Often used in combination with other drugs to suppress the immune system Used to prevent organ rejection post transplantation Not often prescribed to cats due to its toxicity What dogs / cats should not take this medication?

The drug, rapamycin, is an immunosuppressant used to treat certain cancers and also to prevent organ rejection in transplant patients.

Mycophenolate mofetil is approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection in people who have received a kidney, heart, or liver transplant.

«Scientists have not looked carefully at how drugs used to prevent organ rejection can have a detrimental effect on bone, but our study would suggest that if those drugs inhibit mTOR, they could disrupt bone formation.»

«Cancer treatment for transplant patients discovered: Letter notes combination of steroids and immunosuppressants, combined with immune checkpoint inhibitors helps prevent organ rejection in kidney transplant patients undergoing cancer treatment.»

«We used mice with conditions that mimic those often found in transplant patients — hyperlipidemia is common in patients before transplantation but can also be caused by drugs to prevent organ rejection — and discovered that it accelerates organ rejection.

We can completely prevent organ rejection in all animals, also observing that allo - antibodies are virtually absent.

Yet the success of both depends on doctors being able to manipulate the body's immune system, to prevent organ rejection in one case and the overzealous immune responses which appear to cause asthma attacks in the other.

The new technique, described in next month's Nature Medicine, could someday be used to prevent organ rejection in people, as well as eliminate the need for lifelong immune - suppressing drugs that make most transplant recipients susceptible to infections, cancers, and nerve damage.

Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation.

«We think this approach to preventing organ rejection has the potential to offer significant benefits to those in need of heart, lung, liver and bone marrow transplants.»

Crucially, he experimented with, combined and developed drugs to suppress the immune system, thereby preventing organ rejection.

Not exact matches

To prevent transplant rejection in patients with end - stage organ failure, a lifelong regimen of immune - suppressing drugs is almost always required.

Surprisingly, the researchers detected levels of viruses in sepsis patients that were on par with those seen in patients who have had organ transplants and are taking immune - suppression drugs to prevent rejection.

Rapamycin is used in recipients of organ transplants, as it keeps the immune system in check and can consequently prevent rejection of the foreign tissue.

«Long - term prevention of organ rejection: Biologists use immunoproteasome inhibition to prevent chronic antibody - mediated allograft rejection.»

In theory, you could decellularize an organ, and then populate it with the patient's own stem cells which would prevent rejection.

The situation looks a lot like that in kidney transplant patients, who are taking drugs to prevent immune rejection of their new organ, Ford says.

For example, the biology of dendritic cells is now being used to explore vaccines and therapies to prevent infectious diseases, autoimmune disorders, allergy, cancer, and rejection of organ transplants.

One direction is to use drugs already approved to prevent rejection for organ transplant that target the same receptor.

In 1994, Schreiber and co-workers discovered that the proteins FKBP12 and mTOR are the simultaneous targets of the small molecule rapamycin, now approved for use as an immunosuppressant drug given to patients after organ transplantations to help prevent rejection.

The animals were genetically altered to prevent human rejection of transplanted pig organs.

It is used to help prevent rejection after organ transplant operations and also to treat a variety of inflammatory and autoimmune diseases such as rheumatoid arthritis.

Cyclosporin, sold as Atopica, is the same drug that people take to prevent organ transplants rejection.

High doses of rapamycin are already used in humans to fight cancer and prevent organ - transplant rejection, but at low doses, it has also been shown to slow aging and extend life span in several animals with few or no side effects.

An effective long term treatment for atopy relies on cyclosporines, the medication that prevents organ transplant rejections.